STAT

Amgen, Merck, and Eli Lilly sue over Trump administration policy to require drug prices in TV ads

Amgen, Merck, Eli Lilly, and the Association of National Advertisers sued the Trump administration over a new policy to require drug prices in TV ads.

WASHINGTON — A trio of pharmaceutical manufacturers on Friday filed suit to overturn one of the most impactful drug pricing policies the Trump administration has enacted to date: a requirement that the companies include a medicine’s list price in direct-to-consumer advertising.

The drug makers — Amgen, Merck, and Eli Lilly — were joined by

You're reading a preview, sign up to read more.

More from STAT

STAT3 min read
Opinion: Federated Learning: Collaboration Without Compromise For Health Care Research
Here's a new way to learn from massive collections of data while avoiding the privacy and other risks typically associated with sharing such information: federated learning.
STAT8 min readSociety
Understanding Pandemics: What They Mean, Don’t Mean, And What Comes Next With The Coronavirus
What a pandemic? And who declares one? Those questions and more answered in this pandemic explainer.
STAT2 min read
Are E-cigarette Companies Helping Smokers Quit? Survey Suggests Americans Don’t Buy It
Nearly 60% of respondents said they do not believe the e-cigarette industry is working to “be part of the solution to reduce the health effects of smoking.”